| ABIOMED develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily assisting the pumping function of the heart. Co.'s products include: Impella 2.5®, which is a percutaneous micro heart pump with an integrated motor and sensors; Impella CP®, which provides more blood flow than the Impella 2.5; Impella RP®, which is a percutaneous catheter-based axial flow pump; and Impella Connect®, which is a cloud-based technology that enables remote viewing of the Automated Impella Controller for physicians and hospital staff from anywhere with internet connectivity. We show 47 historical shares outstanding datapoints in our ABMD shares outstanding history coverage, used to compute ABMD market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ABMD market cap history over the course of time is important for investors
interested in comparing ABMD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ABMD versus a peer is one thing; comparing
ABMD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ABMD can fluctuate over the course of history.
With this page we aim to empower investors researching ABMD by allowing them to research the ABMD market cap history.